ФИБРИЛЛЯЦИЯ ПРЕДСЕРДИЙ: ТЕРАПЕВТИЧЕСКИЕ ВОЗМОЖНОСТИ ВОССТАНОВЛЕНИЯ И УДЕРЖАНИЯ СИНУСОВОГО РИТМА
Аннотация
Пациенты с наличием фибрилляции предсердий, (ФП) особенно с частыми пароксизмами, имеют высокий риск сердечно-сосудистых осложнений. ФП ассоциируется с увеличением смертности, частоты инсульта и других тромбоэмболических осложнений, госпитализаций, развитием сердечной недостаточности, ухудшением качества жизни, снижением переносимости физической нагрузки и дисфункцией левого желудочка. В статье представлены возможности восстановления и удержания синусового ритма у пациентов с пароксизмальной формой ФП.
Литература
Chen SJ, Yin YH, Dong Y, Fan JQ, Su L. [Efficacy of rate and rhythm control strategy in patients with atrial fibrillation: meta-analysis]. Zhonghua Xin Xue Guan Bing Za Zhi. 2012;40(1):68-72. (Chinese).
Noseworthy PA, Gersh BJ, Kent DM, Piccini JP, Packer DL, Shah ND, Yao X. Atrial fibrillation ablation in practice: assessing CABANA generalizability. Eur Heart J. 2019;40(16):1257-1264. https://doi.org/10.1093/eurheartj/ehz085.
Camm AJ. Left atrial ablation for management of atrial fibrillation: CABANA vs. real-world data. Apples and oranges? Eur Heart J. 2019;40(16):1265-1267. https://doi.org/10.1093/eurheartj/ehz168.
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan G-A, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau J-P, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Russian Journal of Cardiology. 2021;26(9):234-329. https://doi.org/10.15829/1560-4071-2021-4701. https://elibrary.ru/nnletb. (Russian).
Ministerstvo zdravoohranenija Respubliki Belarus. Vybor strategii vedenija pacientov pri ostrom koronarnom sindrome bez podjema segmenta ST. Prilozhenije 3 k postanovleniju № 59 (June 6, 2017) [Internet]. Available from: https://minzdrav.gov.by/upload/dadvfiles/001077_956336_59kp_kardio.pdf (Russian).
Dzaurova KM, Mironov NYu, Yuricheva YuA, Vlodzyanovsky VV, Mironova NA, Laiovich LYu, Malkina TA, Zinchenko LV, Sokolov SF, Golitsyn SP. Efficiency and safety of using the modified protocol for the administration of the domestic class III antiarrhythmic drug for the relief of paroxysmal atrial fibrillation. Terapevticheskii Arkhiv. 2021;93(9):1052-1057. https://doi.org/10.26442/00403660.2021.09.201008. https://elibrary.ru/kbzdwi. (Russian).
Mironov NY, Yuricheva YA, Vlodzyanovskiy VV, Sokolov SF, Dzaurova KM, Golitsyn SP, Shubik YV, Berman MV, Medvedev MM, Rivin AE, Parkhomchuk DS, Barybin AE, Balandin DA, Batalov RE, Terekhov DS, Evstifeev IV, Kildeev IR, Pyataeva OV, Zenin SA. Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness. Rational Pharmacotherapy in Cardiology. 2021;17(2):193-199. https://doi.org/10.20996/1819-6446-2021-03-05. https://elibrary.ru/ecfvjd.
Mironov NY, Yuricheva YA, Vlodzyanovskiy VV, Sokolov SF, Dzaurova KM, Golitsyn SP, Shubik YV, Berman MV, Medvedev MM, Rivin AE, Parkhomchuk DS, Barybin AE, Balandin DA, Batalov RE, Terekhov DV, Evstifeev IV, Kildeev IR, Pyataeva OV, Zenin SA. Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety. Rational Pharmacotherapy in Cardiology. 2021;17(5):668-673. https://doi.org/10.20996/1819-6446-2021-10-06. https://elibrary.ru/ewecxc. (Russian).
Chatterjee S, Sardar P, Lichstein E, Mukherjee D, Aikat S. Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis. Pacing Clin Electrophysiol. 2013;36(1):122-33. https://doi.org/10.1111/j.1540-8159.2012.03513.x.
Arakelyan MG, Bockeria LA, Vasilieva EYu, Golitsyn SP, Golukhova EZ, Gorev MV, Davtyan KV, Drapkina OM, Kropacheva ES, Kuchinskaya EA, Lajovich LYu, Mironov NYu, Mishina IE, Panchenko EP, Revishvili ASh, Rzayev FG, Tatarsky BA, Utsumueva MD, Shakhmatova OO, Shlevkov NB, Shpektor AV, Andreev DA, Artyukhina EA., Barbarash OL, Galyavich AS, et al. 2020 Clinical guidelines for Atrial fibrillation and atrial flutter. Russian Journal of Cardiology. 2021;26(7):4594. https://doi.org/10.15829/1560-4071-2021-4594. https://elibrary.ru/fuzaad. (Russian).
Al-Khatib SM, Allen LaPointe NM, Chatterjee R, Crowley MJ, Dupre ME, Kong DF, Lopes RD, Povsic TJ, Raju SS, Shah B, Kosinski AS, McBroom AJ, Sanders GD. Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review. Ann Intern Med. 2014 Jun 3;160(11):760-73. https://doi.org/10.7326/M13-1467.
Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, Stijnen T, Lip GY, Witteman JC. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27(8):949-53. https://doi.org/10.1093/eurheartj/ehi825.
Revishvili ASh, Sulimov VA. Atrial fibrillation and flutter (practice guidelines). Cardiology: news, opinions, training. 2022;10(4):62-79. edn: QBPSTT. (Russian).
Kurbanov RD, Abdullaev TA. Farmakodinamika i effektivnost allapinina u bolnyh s narushenijami ritma serdca. Clinical Medicine (Russian Journal). 1988;(10):52-55. (Russian).
Kaverina NV, Lyskovtsev VV, Senova ZP, Grigorieva EK. Ethacizine: pharmacologic properties and possibilities of its clinical use. Kardiologiia. 1984;24(5):52-57. (Russian).
Nedostup AV, Blagova OV. Ethasicin in the treatment of arrhythmias. Russian Journal of Cardiology and Cardiovascular Surgery. 2009;2(4):62-68. edn: OZBYGJ. (Russian).
Kukes VG, Shugushev HH, Gneushev ET, et al. Farmakokinetika i farmakodinamika novogo antiaritmicheskogo preparata etacizina pri prieme vnutr. Sovetskaja medicina. 1985;(4):81-82. (Russian).
Lozinsky LG, Zamotayev IP, Kerimova RE, Rakova NA. Results of ethacisine therapy of paroxysmal cardiac fibrillation. Kardiologiia. 1989;29(7):37-40. (Russian).
Sokolov SF. Results of clinical studies of allapinin and up-to-date approaches to treatment of patients with cardiac arrhythmias. Journal of Arrhythmology. 2011;(64):60-70. edn: RRQENH. (Russian).
Sokolov SF, Bomonina EV. Comparative efficacy and safety of allapinine, ethacyzin and amiodarone: choice of optimal antiarrhythmic therapy for rhythm control in case of paroxysmal atrial fibrillation. Cardiology: news, opinions, training. 2015:(3):65-75. edn: UKLKTT. (Russian).
